CURIS Share Price | Curis Lifesciences Ltd Stock Analysis & Recommendation

Q: Why is Curis Lifesciences Ltd falling/rising?

As of 04-Mar, Curis Lifesciences Ltd's stock price is falling, currently at 96.20, reflecting a decrease of 3.75 points or 3.75%. This decline is evident in its performance today, where it underperformed its sector by 2.66%. Additionally, the stock is trading below its moving averages across various periods, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend.Over the past month, the stock has decreased by 9.59%, while year-to-date, it has fallen by 20.23%. Although the stock has shown some resilience in the short term with a slight increase of 0.21% over the past week, it remains close to its 52-week low, just 3.74% above the low of Rs 92.6. Despite a notable increase in investor participation, with delivery volume rising by 150% against the 5-day average, the overall market sentiment appears negative, contributing to the stock's decline.

Technical Trend Update: Curis Lifescien. witnessed a change in Technical Grade on 04 Mar 2026. Click here to discover latest technical change!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

28.0 k (218.18%) Volume

Shareholding (Oct 2025)

FII

0.00%

Held by 0 FIIs

DII

7.32%

Held by 0 DIIs

Promoter

92.68%

Why is Curis Lifesciences Ltd falling/rising?

05-Mar-2026

As of 04-Mar, Curis Lifesciences Ltd's stock price is at 96.20, down 3.75% and underperforming its sector. The stock has decreased 9.59% over the past month and 20.23% year-to-date, indicating a bearish trend despite a recent slight increase in investor participation.

View full answer

Which are the latest news on Curis Lifescien.?

05-Mar-2026

No latest news for Curis Lifescien. found.

Compare Curis Lifescien. with Similar Stocks

Accretion Pha.Bharat Immunolog Zenith Drugs

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 78 Cr (Micro Cap)

P/E

13.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.72

Return on Equity

30.38%

Price to Book

3.81

Revenue and Profits:

Net Sales:

20 Cr

(Quarterly Results - Jun 2025)

Net Profit:

3 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-22.24%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Curis Lifescien. for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

6.25

Debt to EBITDA (avg)

1.42

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.50

Tax Ratio

30.92%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

13.79%

ROCE (avg)

30.11%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.84

EV to EBIT

9.26

EV to EBITDA

8.68

EV to Capital Employed

2.65

EV to Sales

1.85

PEG Ratio

Dividend Yield

ROCE (Latest)

28.59%

ROE (Latest)

30.38%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

KST

Dow Theory

Mildly Bullish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Oct 2025

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Pawasia Siddhant J (19.05%)

Highest Public shareholder

Strategic Sixth Sense Capital Fund (2.04%)

Individual Investors Holdings

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19.50",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.23",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.29",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.87",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.69%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Curis Lifescien."
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Curis Lifescien."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Curis Lifescien."
  }
]

Quarterly Results Snapshot (Standalone) - Jun'25 - QoQ

Jun'25

Change(%)

Net Sales

19.50

Operating Profit (PBDIT) excl Other Income

4.23

Interest

0.29

Exceptional Items

0.00

Standalone Net Profit

2.87

Operating Profit Margin (Excl OI)

21.69%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Quarterly Results

Company CV

About Curis Lifesciences Ltd

Curis Lifesciences Ltd

Micro Cap

Pharmaceuticals & Biotechnology

Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of "M/s Loreto Pharmaceutacals", pursuant to a Deed of Partnership dated 2 June, 2010. Thereafter " M/s Loreto Pharmaceutacals" was converted from Partnership Firm to a Private Limited Company as "Curis Lifesciences Private Limited" and received a Certificate of Incorporation dated on March 23rd, 2016 issued by Registrar of Companies, Ahmedabad.

Company Coordinates

No Company Details Available